U.S. Physical Therapy (USPH) and Its Rivals Financial Survey
U.S. Physical Therapy (NYSE: USPH) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it contrast to its competitors? We will compare U.S. Physical Therapy to related businesses based on the strength of its profitability, risk, valuation, analyst recommendations, earnings, dividends and institutional ownership.
This is a breakdown of current ratings and price targets for U.S. Physical Therapy and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|U.S. Physical Therapy||0||2||2||0||2.50|
|U.S. Physical Therapy Competitors||57||326||509||9||2.52|
Earnings and Valuation
This table compares U.S. Physical Therapy and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|U.S. Physical Therapy||$356.55 million||$20.55 million||42.56|
|U.S. Physical Therapy Competitors||$1.06 billion||-$22.56 million||686.00|
U.S. Physical Therapy’s competitors have higher revenue, but lower earnings than U.S. Physical Therapy. U.S. Physical Therapy is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This table compares U.S. Physical Therapy and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|U.S. Physical Therapy||5.29%||13.37%||6.63%|
|U.S. Physical Therapy Competitors||3.52%||3.52%||4.31%|
Volatility and Risk
U.S. Physical Therapy has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, U.S. Physical Therapy’s competitors have a beta of 0.83, meaning that their average share price is 17% less volatile than the S&P 500.
Insider and Institutional Ownership
99.8% of U.S. Physical Therapy shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 3.1% of U.S. Physical Therapy shares are held by company insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
U.S. Physical Therapy pays an annual dividend of $0.80 per share and has a dividend yield of 1.1%. U.S. Physical Therapy pays out 48.2% of its earnings in the form of a dividend. As a group, “Hospitals, Clinics & Primary Care Services” companies pay a dividend yield of 1.0% and pay out 37.9% of their earnings in the form of a dividend. U.S. Physical Therapy has raised its dividend for 6 consecutive years.
U.S. Physical Therapy competitors beat U.S. Physical Therapy on 8 of the 15 factors compared.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company’s segment is made up of various clinics within partnerships. The Company primarily operates through subsidiary clinic partnerships, in which it owns a general partnership interest and a limited partnership interest, and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company operates 562 physical therapy clinics in 42 states. There are approximately 380 clinics operated under Clinic Partnerships and over 100 operated as Company-owned Facilities. In addition to its owned clinics, it also manages physical therapy facilities for third parties, primarily physicians, with over 29 third-party facilities under management.
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.